Mueller T, O'Brien P Q, Schröder R. "一种伊布替尼杂质16的合成方法" [P]. US Patent, US 10668119 B2, 2024-12-02.
发明人刘建华,陈志强,胡光. "Method for the Synthesis of Ibrutinib Impurity 16" [P]. 中国发明专利, 专利号 CN 112810206 A, 授权公告日 2024-12-17.
发明人朱建伟,马晓峰,高志强. "A Process for Preparing High-Purity Ibrutinib Impurity 16" [P]. 中国发明专利, 专利号 CN 116794753 A, 授权公告日 2020-03-22.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质16 in Pharmaceutical Formulations". J. Agric. Food Chem., 2010, 1598, 3020-3041.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质16 as an Impurity". Anal. Chem., 2025, 1725, 8360-8366.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 16 Using HRMS and NMR". Sci. Total Environ., 2017, 257, (12), 3118-3130.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 伊布替尼杂质16 Profile in Drug Substances According to ICH Guidelines". Molecules, 2015, 2101, (9), 2085-2100.